PRODUCT INFORMATION
Fatty Acid Amide Hydrolase (human recombinant)
Item No. 10010183
Overview and Properties
Synonym:FAAH
Source:
Recombinant human C-terminal His-tagged protein expressed in Sf21 cells
Uniprot No.:O00519
Batch specific information can be found on the Certificate of Analysis or by contacting Technical Support
Molecular Weight: 64.3 kDa
Storage:
-80°C (as supplied)
Stability:
≥6 months
Purity:
batch specific
Supplied in:
batch specific
Protein
Concentration:
batch specific mg/ml
Activity:
batch specific U/ml
Specific Activity: batch specific U/mg
Unit Definition:
One unit is defined as the amount of enzyme required to produce 1 pmole of AMC
per minute in 50 mM Tris, pH 9.0, 1 mM EDTA and 20 µM AMC Arachidonyl Amide
(AMCAA) at 37°C.​​
Image(s)
1
25000
20000
· · · · · · ·67.5 kDa
AFU
15000
10000
5000
0
FAAH +AMCAA
FAAH + AMCAA +
URB597
Figure 1: Inhibition of FAAH by URB597
Lane 1: FAAH 100,000 x g supernatant
Figure 2: Western blot of FAAH (human
recombinant) probed using Cayman’s
FAAH Polyclonal Antibody
(Item No. 101600).
WARNING
THIS PRODUCT IS FOR RESEARCH ONLY - NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.
SAFETY DATA
This material should be considered hazardous until further information becomes available. Do not ingest, inhale, get in eyes, on skin, or on clothing. Wash thoroughly after
handling. Before use, the user must review the complete Safety Data Sheet, which has been sent via email to your institution.
WARRANTY AND LIMITATION OF REMEDY
Buyer agrees to purchase the material subject to Cayman’s Terms and Conditions. Complete Terms and Conditions including Warranty and Limitation of Liability information
can be found on our website.
Copyright Cayman Chemical Company, 06/02/2017
CAYMAN CHEMICAL
1180 EAST ELLSWORTH RD
ANN ARBOR, MI 48108 · USA
PHONE: [800] 364-9897
[734] 971-3335
FAX:[734] 971-3640
[email protected]
WWW.CAYMANCHEM.COM
PRODUCT INFORMATION
Description
The endocannabinoid system is a ubiquitous lipid signaling system that is involved in various
regulatory functions throughout the body. The main endocannabinoids are arachidonoyl ethanolamide
(AEA; Item No. 90050) and 2-arachidonoyl glycerol (2-AG; Item No. 62160). They bind to G protein-coupled
receptors, of which the central cannabinoid (CB1) receptor is densely distributed in areas of the brain related
to motor control, cognition, emotional responses, and homeostasis.1-4 Acting via the peripheral cannabinoid
(CB2) receptor in the peripheral tissues, the endocannabinoid system is one of the crucial modulators of
the autonomic nervous system, the immune system, and microcirculation. Endocannabinoids are released
upon demand from lipid precursors in a receptor-dependent manner. They are transported into cells by
an apparently specific uptake system and degraded primarily by two enzymes, fatty acid amide hydrolase
(FAAH) and monoacylglycerol lipase (MAGL), resulting in the termination of their biological actions.5 FAAH,
a serine hydrolase, can degrade many fatty acid amides, including AEA. Although FAAH can hydrolyze 2-AG,
the main enzyme responsible for the inactivation of this monoglyceride is another serine hydrolase, MAGL.
Finding inhibitors to these endocannabinoid hydrolases could offer another approach in the treatment
of pain, obesity, and various neurological diseases, where higher endocannabinoid activity would be
beneficial. An advantage of such enzyme inhibition over direct CB agonists could result in higher selectivity,
as it would increase activity of the endocannabinoid system only at sites where on-going production of
endocannabinoids is taking place.6
References
1. Stella, N., Schweitzer, P., and Piomelli, D. A second endogenous cannabinoid that modulates long-term
potentiation. Nature 388, 773-778 (1997).
2. Sugiura, T., Kodaka, T., Nakane, S., et al. Evidence that the cannabinoid CB1 receptor is a
2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked
analogues, and related compounds. J. Biol. Chem. 274, 2794-2801 (1999).
3. Kondo, S., Kondo, H., Nakane, S., et al. 2-Arachidonoylglycerol, an endogenous cannabinoid receptor
agonist: Identification as one of the major species of monoacylglycerols in various rat tissues, and
evidence for its generation through Ca2+-dependent and -independent mechanisms. FEBS Lett. 429,
152-156 (1998).
4. Rodríguez De Fonseca, F., Del Arco, I., Bermudez-Silva, F., et al. The endocannabinoid system: Physiology
and pharmacology. Alcohol Alcohol. 40(1), 2-14 (2005).
5. Dinh, T.P., Carpenter, D., Leslie, F.M., et al. Brain monoglyceride lipase participating in endocannabinoid
inactivation. Proc. Natl. Acad. Sci. USA 99(16), 10819-10824 (2002).
6. Lambert, D.M. and Fowler, C.J. The endocannabinoid system: Drug targets, lead compounds, and
potential therapeutic applications. J. Med. Chem. 48(16), 5059-5087 (2005).
CAYMAN CHEMICAL
1180 EAST ELLSWORTH RD
ANN ARBOR, MI 48108 · USA
PHONE: [800] 364-9897
[734] 971-3335
FAX:[734] 971-3640
[email protected]
WWW.CAYMANCHEM.COM